Filing Details
- Accession Number:
- 0001140361-15-012986
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-23 20:31:55
- Reporting Period:
- 2015-03-19
- Filing Date:
- 2015-03-23
- Accepted Time:
- 2015-03-23 20:31:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1302573 | Oncomed Pharmaceuticals Inc | OMED | Pharmaceutical Preparations (2834) | 383572512 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1503062 | Sunil Patel | C/O Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-19 | 3,335 | $3.42 | 23,335 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-19 | 3,335 | $27.34 | 20,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-03-20 | 14,665 | $3.42 | 34,665 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-20 | 14,665 | $27.86 | 20,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-03-19 | 3,335 | $0.00 | 3,335 | $3.42 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-03-20 | 14,665 | $0.00 | 14,665 | $3.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 116,260 | 2019-07-30 | No | 4 | M | Direct | |
| 101,595 | 2019-07-30 | No | 4 | M | Direct |
Footnotes
- Includes 20,000 Restricted Stock Units.
- Transaction executed in multiple trades at prices ranging from $27.34 to $27.3701 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Transaction executed in multiple trades at prices ranging from $27.66 to $27.99 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
